FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

5033311000001102: Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
23434901000001116 Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
23435001000001116 Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram Is pack of Lidocaine 5% / Hydrocortisone acetate 0.275% ointment false Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram Has active ingredient Hydrocortisone acetate false Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram Has active ingredient Lidocaine false Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram Has manufactured dose form Ointment false Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram Has VMP Lidocaine 5% / Hydrocortisone acetate 0.275% ointment true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram Has specific active ingredient Hydrocortisone acetate true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram Has specific active ingredient Lidocaine true Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Xyloproct ointment (AstraZeneca) 20 gram Is a True Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram Inferred relationship Existential restriction modifier
Lidocaine 5% / Hydrocortisone acetate 0.275% ointment (Ennogen Healthcare Ltd) 20 gram Is a False Lidocaine 5% / Hydrocortisone acetate 0.275% ointment 20 gram Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start